MAM
Majedie Asset Management’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | $8.13M | Sell |
187,150
-42,111
| -18% | -$1.83M | 0.67% | 53 |
|
2021
Q4 | $10.1M | Buy |
229,261
+18,229
| +9% | +$805K | 0.77% | 40 |
|
2021
Q3 | $8.07M | Sell |
211,032
-1,209
| -0.6% | -$46.2K | 0.61% | 59 |
|
2021
Q2 | $8.46M | Sell |
212,241
-35,012
| -14% | -$1.39M | 0.56% | 63 |
|
2021
Q1 | $8.83M | Buy |
247,253
+39,388
| +19% | +$1.41M | 0.64% | 49 |
|
2020
Q4 | $7.66M | Sell |
207,865
-21,796
| -9% | -$803K | 0.59% | 47 |
|
2020
Q3 | $8.65M | Sell |
229,661
-5,405
| -2% | -$204K | 0.64% | 38 |
|
2020
Q2 | $9.59M | Sell |
235,066
-95,352
| -29% | -$3.89M | 0.73% | 31 |
|
2020
Q1 | $12.5M | Sell |
330,418
-39,086
| -11% | -$1.48M | 1.16% | 18 |
|
2019
Q4 | $17.4M | Buy |
369,504
+941
| +0.3% | +$44.3K | 1.26% | 19 |
|
2019
Q3 | $15.7M | Sell |
368,563
-264,064
| -42% | -$11.3M | 1.34% | 17 |
|
2019
Q2 | $25.4M | Sell |
632,627
-449,779
| -42% | -$18M | 1.95% | 9 |
|
2019
Q1 | $45.3M | Sell |
1,082,406
-53,253
| -5% | -$2.23M | 3.2% | 7 |
|
2018
Q4 | $44.4M | Buy |
+1,135,659
| New | +$44.4M | 3.3% | 8 |
|